Skip to main content

Biologics & Biosimilars – An Overview for Healthcare Providers

Biologics & Biosimilars – An Overview for Healthcare Providers

Original Air Date : September 5, 2024

Original Air Date : September 5, 2024

In the treatment of osteoporosis, biologic and biosimiar medications may be provided as part of a treatment plan. What do healthcare providers need to know?

Join Dr. Alan Low as he shares information on Biologics & Biosimilars – An Overview for Healthcare Providers. Information presented will include how biologics and biosimilars work, the benefits of biosimilars and how to speak to patients about these new treatment options.


PRESENTERS

Dr. Alan Low

Dr. Alan Low

BSc.(Pharm.), Pharm D., RPh, ACPR, FCSHP, CCD
Dr. Alan Low is a Clinical Professor in the Faculty of Pharmaceutical Sciences at the University of British Columbia, Care Director at MedInfuse Health, and Primary Care Pharmacist / Pharmacy Lead at BioPro Biologics Pharmacy. He is a member of Osteoporosis Canada’s Scientific Advisory Council, Board Advisor with the GI Society and a member of the Medical Board of HealthChoicesFirst.com, a patient video education resource. Dr. Low has experience in a wide variety of health and administrative settings including direct patient care in the hospital and clinics, clinical and practice-based research, consultant in healthcare and clinical projects as well as health advocacy. Together with a nurse educator and rheumatologist, Dr. Low has coauthored “The Osteoporosis Book, 4th Edition: Bone Health”. In addition, he has been the Co-Editor of the Health Matters Bulletin, published articles in scientific and health journals and newsletters, and is a founding Co-Editor of the Pharmacy Management in Canada textbook.

MODERATORS

Kerry Grady

Kerry Grady

MHSC, Senior Manager, Scientific and Clinical Programs, Osteoporosis Canada

STAY INFORMED

Get Osteoporosis updates, news and stories. We also inform you of upcoming events and live webinars, don’t miss out, join today!

OC REPLAY WEBINARS – RECENT ITEMS

X-Linked Hypophosphatemia (XLH): Healthcare Provider Webinar

X-linked hypophosphatemia (XLH) is a rare genetic disorder that affects bone and dental health. It is characterized by low levels of the mineral phosphorus (sometimes referred to as “phosphate”) in the blood due to abnormal processing by the kidneys. Join Dr. Angela Cheung as she will discusses what XLH is, the cause…

Protein and Fragility: What You Need To Know

In Partnership with Canada Beef Osteoporosis Canada To stay healthy and independent as we grow older, it’s important to tackle common challenges like chronic illnesses, broken bones, muscle loss, frailty, and falls, all of which can be improved with good nutrition. Join Dr. Wendy Ward and Dr. Tyler Churchward-Venne…

Eat Well On A Budget

In Partnership with Canada Beef Tips and strategies on how to get the nutrients we need from nourishing foods. Osteoporosis Canada recommends that whenever possible to get bone building nutrients through food sources. But that may be a challenge as grocery prices continue to rise making it more difficult to access…
© Osteoporosis Canada, 2025
Charitable Registration No. 89551 0931 RR 0001